These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3908020)

  • 21. Hemolytic episode in a patient with Wilson's disease treated with zinc.
    Shimon I; Moses B; Sela BA; Dolev E
    Isr J Med Sci; 1993 Oct; 29(10):646-7. PubMed ID: 8244665
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
    Yang RM
    Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875
    [No Abstract]   [Full Text] [Related]  

  • 23. Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
    Yeh SJ; Leu ML; Strickland GT
    J Lab Clin Med; 1971 Mar; 77(3):438-44. PubMed ID: 5553728
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillamine hepatotoxicity in the treatment of Wilson's disease.
    Menara M; Zancan L; Sturniolo GC
    J Pediatr Gastroenterol Nutr; 1992 Apr; 14(3):353-4. PubMed ID: 1619543
    [No Abstract]   [Full Text] [Related]  

  • 25. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease.
    Pasqualicchio M; Milanino R; Marrella M; Moretti U; Tomelleri G; Velo GP
    Pharmacol Res; 1989; 21 Suppl 1():151-2. PubMed ID: 2633173
    [No Abstract]   [Full Text] [Related]  

  • 26. [Wilson's disease. II].
    Sánchez Rodríguez A; González Macías J; Díez Jarilla JL; Suquia Múgica B; de Portugal Alvarez J
    Rev Esp Enferm Apar Dig; 1982 Aug; 62(2):142-53. PubMed ID: 6755575
    [No Abstract]   [Full Text] [Related]  

  • 27. Nuclear magnetic resonance brain study in a case of Wilson disease.
    Longhi R; Riva E; Rottoli A; Valsasina R; Pinelli P; Giovannini M
    J Inherit Metab Dis; 1989; 12 Suppl 2():386-8. PubMed ID: 2512451
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral zinc sulphate treatment in Wilson's disease.
    Pasqualicchio M; Marrella M; Moretti U; Velo GP; Deganello A; Tomelleri G; Milanino R
    Acta Physiol Hung; 1990; 75 Suppl():233-4. PubMed ID: 2371874
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis of asymptomatic forms of hepatolenticular degeneration].
    Kuncová Z; Dittrich J; Nevsímalová S; Marecek Z; Heyrovský A
    Cesk Pediatr; 1971 Apr; 26(4):166-9. PubMed ID: 5553356
    [No Abstract]   [Full Text] [Related]  

  • 30. Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.
    Hoogenraad TU; Rothuizen J
    Lancet; 1986 Jul; 2(8499):170. PubMed ID: 2873435
    [No Abstract]   [Full Text] [Related]  

  • 31. Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration.
    Hartard C; Weisner B; Dieu C; Kunze K
    J Neurol; 1993 Dec; 241(2):101-7. PubMed ID: 8138824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc therapy as the initial treatment for Wilson's disease.
    Hoogenraad TU; Van Hattum J
    Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392
    [No Abstract]   [Full Text] [Related]  

  • 33. [New views on the etiology, diagnosis and therapy of Wilson's disease].
    Linke A
    Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1273-6. PubMed ID: 4873428
    [No Abstract]   [Full Text] [Related]  

  • 34. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 35. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).
    PALMER JF; DREW AL; CHENOWETH MB
    Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful medical treatment of severely decompensated Wilson disease.
    Santos Silva EE; Sarles J; Buts JP; Sokal EM
    J Pediatr; 1996 Feb; 128(2):285-7. PubMed ID: 8636833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 38. Pregnancy and Wilson's disease.
    Chin RK
    Am J Obstet Gynecol; 1991 Aug; 165(2):488-9. PubMed ID: 1872365
    [No Abstract]   [Full Text] [Related]  

  • 39. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B; el-Kamel M
    Tunis Med; 1974; 52(1):29-31. PubMed ID: 4215182
    [No Abstract]   [Full Text] [Related]  

  • 40. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.